Johnson & Johnson Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 382 Posts
1 2 3 ... 24
Negative News Response Syndrome For Stocks?
Article By: Kurt Kallaus Sunday, October 21, 2018 4:48 PM EST
With the heart of the current earnings season for stocks running from October 16 to November 14, it’s too early to prognosticate with confidence, but there appears to be a shift in how the market is responding to good and bad news.
In this article: CSX, JNJ, PG, UNH, NFLX, PYPL
Read
Johnson & Johnson (JNJ) Surpasses Q3 Earnings And Revenue Estimates
Article By: Zacks Investment Research Tuesday, October 16, 2018 10:36 AM EST
Johnson & Johnson came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $2.03 per share.
In this article: JNJ
Read
Banks Provide Positive Start To Q3 Earnings Season
Article By: Sheraz Mian Saturday, October 13, 2018 5:51 PM EST
Bank stocks have been notable laggards in recent quarters, with market participants preferring the faster growing technology stocks to these seemingly boring companies. Banks are boring, but they have a lot going for them.
In this article: JNJ, SLB, NFLX
Read
E Johnson & Johnson: Recession Safety, Growth And Valuation
Article By: SureDividend Sunday, September 30, 2018 10:26 AM EST
it is a shame to miss the exceptional long-term returns of the stock market due to abstract fears of a bear market.
In this article: JNJ Also: GILD
Read
A Pause That Refreshes?
Article By: Lance Roberts Saturday, September 29, 2018 5:44 PM EST
Tariffs, higher interest rates, and higher oil prices are ultimately a direct tax on the consumer. Such will ultimately weigh on consumption, earnings, and the economy. Another concern for the rally is the participation continues to narrow.
In this article: SPX, XLRE, XLC, JNJ, PEP, SU, KLAC, MU, GLD
Read
E JNJ Trade Idea
Article By: Gavin McMaster Monday, September 24, 2018 9:30 PM EST
Last week, JNJ had the highest RSI reading of any stock in the Dow Jones Index.
In this article: JNJ
Read
Bulls Charge To All-Time Highs
Article By: Lance Roberts Saturday, September 22, 2018 6:35 PM EST
Get out your party hats, the markets hit all-time highs this past week. After increasing equity exposure in portfolios on the 11th, as the markets pulled back to the previous break-out support levels, I suggested a push to new highs was likely.
In this article: CVS, FDX, JNJ, NKE, PEP, WMT, SPY, DUK
Read
Why Valuation Determines Total Dividend Payments For Overvalued Stocks; Johnson & Johnson Case Study
Video By: Chuck Carnevale Saturday, September 15, 2018 9:29 AM EST
Valuation not only has a material impact on dividend income, it also has a major impact on total return.
In this video: JNJ
Watch
E Johnson & Johnson Is A Forever Stock
Article By: SureDividend Wednesday, August 29, 2018 12:39 PM EST
See the investment prospects of 'forever stock' Johnson & Johnson analyzed in detail.
In this article: JNJ
Read
Geron Soars After Johnson & Johnson Job Posting Mentions Imetelstat
Article By: The Fly Friday, August 24, 2018 8:43 PM EST
The move higher in shares of Geron (GERN) is being attributed to a Johnson & Johnson (JNJ) job opening on LinkedIn for an "EMEA Strategic Pricing Manager" role that would "also be accountable for shaping our pricing approach for Imetelstat."
In this article: JNJ, GERN
Read
5 Hot Stocks In The Dow ETF Last Week
Article By: Sweta Killa Monday, August 20, 2018 12:45 PM EST
Though most of the stocks in the fund’s portfolio have rebounded strongly, a few led the way higher over the past five days.
In this article: WMT, VZ, CSCO, AAPL, JNJ Also: DIA
Read
My Top 10 Buy & Hold Forever Stocks
Article By: SureDividend Thursday, August 16, 2018 12:28 PM EST
Many of these 10 are not buys today. But they should still be on investor’s radars.
In this article: JNJ, ABT, MMM, MCD, CHD, HRL, COST, XOM, BF-B, KMB
Read
August 11, 20018 Week In Review: How Trump's Policies Moved Stocks
Article By: The Fly Saturday, August 11, 2018 9:37 PM EST
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Trump and his administration with this weekly recap.
In this article: L, AA, AKS, BA, CLF, JNJ, NUE, X, DDAIF, RHHBY, REGN, AAPL, AMGN, CENX, STLD
Read
Biotechs Hold And Ignore Rocky Week Of Global Politics - Big Earnings Upcoming… Updates CELG, BIIB, AZN, XBI
Article By: Rod Raynovich Saturday, July 28, 2018 9:15 PM EST
Biotech and Tech stocks teetered near highs for the year despite all the political drama of Putin and Trump at Helsinki, Russian “Spy” at the NRA, Tariffs and Trade War, Brexit Uncertainty, currency volatility and the Powell FED rate hike policy.
In this article: AZN, BIIB, LLY, CELG, RHHBY, VRTX, BMY, AMGN, GILD, ABBV, HON, JNJ, AGIO
Read
Biotechs Cruise Onto Green Screen: July Looks Good
Article By: Rod Raynovich Thursday, July 19, 2018 12:16 PM EST
Biotechs cruised through the choppy market of late June to rally with many mid-caps rolling up and major ETFs up creeping toward 2018 highs. However, with earnings reports coming up, we could expect some selling depending on top line growth.
In this article: FBT, MRK, NVS, ACAD, IBB, CELG, VRTX, XBI, NVCR, CRSP, AMGN, CTNI, JNJ
Read
Johnson & Johnson CFO On Q2 Earnings Beat
Video By: CNBC Tuesday, July 17, 2018 8:53 AM EST
Johnson & Johnson CFO, breaks down the company's quarterly numbers which beat on the top and bottom line, helped by improved cancer drug sales.
In this video: JNJ
Watch
1 to 16 of 382 Posts
1 2 3 ... 24